Acute myocardial infarction
MONDO:0004781Necrosis of the myocardium, as a result of interruption of the blood supply to the area. It is characterized by a severe and rapid onset of symptoms that may include chest pain, often radiating to the left arm and left side of the neck, dyspnea, sweating, and palpitations.
Also known as: acute myocardial infarction (disease), myocardial infarction (disease), acute
346 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Which strategy wins for heart attack patients with multiple blocked arteries?
Disease control OngoingThis trial investigates the best way to treat people who have a heart attack and also have other narrowed arteries. It compares doing an immediate procedure to open those other arteries, guided by a pressure wire, versus waiting and using a heart scan to decide later. The goal is…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could dropping aspirin after a heart attack save hearts?
Disease control OngoingThis trial asks whether giving only ticagrelor (a blood thinner) after a heart attack, instead of the usual ticagrelor plus aspirin, is just as safe and might reduce bleeding and heart muscle damage. About 200 people who had a type of heart attack called STEMI and underwent a ste…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New camera could save hearts: OCTAVE trial tests smarter stent placement
Disease control ENROLLING_BY_INVITATIONThis study tests whether using a special camera (OCT) inside the heart's arteries during a heart attack procedure leads to better outcomes than the standard X-ray method. About 3000 people having a heart attack will be randomly assigned to one of the two approaches. The goal is t…
Phase: NA • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Heart attack survivors: could a new shot clear your clogged arteries?
Disease control OngoingThis study tests if a drug called inclisiran can reduce fatty plaque buildup in the arteries of people who recently had a heart attack and have high cholesterol. About 318 adults will receive either inclisiran or standard care, and doctors will use special imaging to measure plaq…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a Pen-Sized shot stop a heart attack in its tracks?
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called selatogrel, which people inject themselves at the first sign of a heart attack. The goal is to see if it can prevent death or reduce heart damage. The trial involves 25,000 people who recently had a heart attack and have other risk factors. Particip…
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Stenting unstable plaques: a new way to prevent second heart attacks?
Disease control OngoingThis study looks at 600 people who had a major heart attack and have other narrowings in their heart arteries that are not severe but look unstable. Half will get a stent plus medication, and half will get medication alone. The goal is to see if stenting these unstable plaques re…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Timing of additional artery opening after heart attack could save lives
Disease control OngoingThis trial looks at the best time to reopen other blocked arteries in people who have just had a major heart attack (STEMI) and have multiple narrowed heart arteries. Participants are randomly assigned to have all blockages fixed right away or in a separate procedure later. A spe…
Phase: NA • Sponsor: Chonnam National University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New study aims to get more heart patients into rehab
Disease control OngoingThis study tests whether a personalized 12-week cardiac rehabilitation program, offered in a safety net clinic, helps more heart patients attend rehab compared to the usual referral to an outside program. Researchers will enroll 100 adults who have had a heart attack, surgery, or…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Heart stem cell trial pulled before it even started
Disease control TerminatedThis trial aimed to test whether umbilical cord stem cells, delivered through a catheter into heart arteries, could safely improve heart function in people with severe heart damage after a major heart attack. It was designed for patients with very weak hearts (ejection fraction b…
Phase: PHASE1 • Sponsor: Shanghai Life Science & Technology • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can a 14-Day Anti-Inflammatory shot stop heart failure after a heart attack?
Disease control OngoingThis study tests whether a drug called anakinra, which reduces inflammation, can help prevent heart failure in people who have just had a heart attack. About 84 participants will receive daily injections of anakinra or a placebo for up to 14 days. The goal is to see if blocking i…
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New imaging technique could save lives after heart attacks
Disease control OngoingThis study compares two ways to decide which blocked arteries to stent in heart attack patients who have multiple blockages. One method uses standard X-ray images; the other uses a computer analysis of those images to measure blood flow. About 1,800 patients will be randomly assi…
Phase: NA • Sponsor: University Hospital of Ferrara • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Cooling the heart during a heart attack: a trial that never got started
Disease control TerminatedThis study planned to test whether cooling the body before and after opening a blocked artery could help people having a heart attack. It was designed to include 80 patients at up to 15 hospitals. However, the trial was withdrawn before anyone was enrolled, so we have no informat…
Phase: NA • Sponsor: ZOLL Circulation, Inc., USA • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Diabetes drug could shield heart muscle during angioplasty
Disease control OngoingThis phase 2 trial tests whether empagliflozin (Jardiance), a diabetes drug, can reduce the 'no-reflow' phenomenon—when blood flow fails to fully restore after angioplasty—in 162 heart attack patients. Participants receive a loading dose before the procedure and daily doses for 3…
Phase: PHASE2 • Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New study tests powerful cholesterol drug right after heart attacks
Disease control OngoingThis study tests whether adding evolocumab (Repatha) to standard care helps people who recently had a heart attack reach very low LDL cholesterol levels and avoid death or unplanned heart-related hospital stays. About 2,166 participants with STEMI or NSTEMI will be randomly assig…
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Clot-Sucking catheter may boost heart attack outcomes
Disease control OngoingThis study compares using a manual clot-removal catheter (Export) before standard balloon angioplasty versus angioplasty alone in 300 heart attack patients with completely blocked arteries. The goal is to see if removing the clot first improves blood flow and reduces in-hospital …
Phase: NA • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New device aims to limit heart damage during heart attacks
Disease control OngoingThis study tests a new device called enVast that removes blood clots from heart arteries during a severe heart attack (STEMI). About 148 adults with large clots will either get standard care or standard care plus the enVast device. The goal is to see if the device reduces the siz…
Phase: NA • Sponsor: Vesalio • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental antibody aims to shield hearts after stent treatment
Disease control OngoingThis early-stage study tests a monoclonal antibody called atibuclimab (IC14) in 10 adults who had a severe heart attack (STEMI) and received a stent. The drug is given by IV to see if it can prevent further heart muscle damage and reduce inflammation. Participants are compared to…
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could freezing dangerous heart plaque stop a heart attack?
Disease control OngoingThis early study tests a new freezing treatment for people who recently had a heart attack or unstable chest pain. The treatment uses a special balloon to freeze high-risk plaque in the heart's arteries that could rupture and cause another heart attack. The goal is to stabilize t…
Phase: NA • Sponsor: Cryotherapeutics SA • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart pump before angioplasty may limit attack damage
Disease control OngoingThis study tests if using a temporary heart pump (Impella CP) for 30 minutes before opening a blocked artery can reduce heart muscle damage in people having a severe heart attack. About 527 adults with a first-time anterior heart attack are enrolled. The goal is to see if this ap…
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Heart attack recovery gets a digital boost: pharmacists take the lead
Disease control OngoingThis study tests a new care model for people who have had a heart attack. It uses digital tools and specially trained pharmacists to help manage health after leaving the hospital. The goal is to reduce the risk of another heart attack or death. The study involves 1,633 adults in …
Phase: NA • Sponsor: National University Heart Centre, Singapore • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Heart clot showdown: new blood thinner vs. old standard in major trial
Disease control OngoingThis study tests whether a newer type of blood thinner (DOA) works better than the standard one (VKA) for dissolving dangerous blood clots inside the heart. About 340 adults with such clots will be randomly assigned to one of the two treatments. The goal is to see which drug redu…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Heart attack procedure under review: does PCI save more lives?
Disease control OngoingThis study tracks over 1,300 heart attack patients who received a procedure called percutaneous coronary intervention (PCI), which opens blocked heart arteries. Researchers want to see if PCI reduces major heart problems like death, another heart attack, or the need for more proc…
Phase: NA • Sponsor: Kaiyang Lin • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Blood test may cut bleeding risk for heart patients on strong meds
Disease control OngoingThis study tests whether a blood test can help doctors safely lower the dose of strong blood thinners (P2Y12 inhibitors) in people who recently had a heart attack or stent. The goal is to reduce bleeding complications without raising the risk of another heart attack or stroke. Ab…
Phase: PHASE4 • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Ambulance injection could change heart attack care
Disease control OngoingThis study tests a single injection of zalunfiban given in the ambulance to people having a severe type of heart attack (STEMI). The goal is to see if the drug improves blood flow and reduces complications like death, stroke, or heart failure within 30 days. About 2,463 participa…
Phase: PHASE3 • Sponsor: CeleCor Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Heart attack patients get early drug to cut risk of another attack
Disease control OngoingThis study tests whether giving evolocumab, a powerful cholesterol-lowering drug, very early during a heart attack hospital stay can reduce the chance of another heart attack, stroke, or death. About 6,000 adults hospitalized for a heart attack are randomly assigned to receive ev…
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Heart attack gene therapy trial pulled before it began
Disease control TerminatedThis study aimed to test a gene therapy called VM202RY in people who recently had a heart attack. The treatment was injected directly into the heart muscle to help it heal and improve pumping strength. However, the trial was withdrawn before enrolling any participants, so no data…
Phase: PHASE2 • Sponsor: Helixmith Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
CT scan could spare many heart attack patients from invasive procedures
Diagnosis OngoingThis trial tests whether a coronary CT angiography (CCTA) scan can safely identify heart attack patients who do not need invasive angiography. About 300 patients with non-ST-elevation myocardial infarction (NSTEMI) will undergo CCTA before the standard invasive test. The goal is …
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
New rapid blood test could cut hospital referrals for chest pain
Diagnosis OngoingThis study tests a new rapid blood test that can detect heart damage in about an hour, right in emergency primary care clinics. Researchers will enroll 2,500 adults with chest pain across six Norwegian clinics to see if the test safely rules out heart attacks and reduces hospital…
Phase: NA • Sponsor: University of Oslo • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
AI reads your Heart's electrical signals to find hidden blockages
Diagnosis OngoingThis study enrolls 800 patients having heart attacks to test an artificial intelligence model that reads standard 12-lead ECGs. The AI aims to detect which artery is blocked and how severely blood flow is reduced, at the moment of a heart catheterization. If accurate, this could …
Sponsor: Powerful Medical • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
One-Hour heart attack test could save lives and slash ER wait times
Diagnosis OngoingThis study compares two blood test schedules for diagnosing heart attacks in the emergency room: the standard 3-hour test and a newer 1-hour test. Over 64,000 adults with chest pain will be enrolled to see if the faster test is just as safe and accurate. If it works, patients cou…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
AI reads your Heart's future: new study aims to predict heart attacks from simple ECG
Diagnosis OngoingThis large observational study involving 150,000 people tests whether artificial intelligence can predict new heart attacks by analyzing electrocardiogram (ECG) images. The AI model, called AMIdECG, looks at past ECG data that was considered normal to see if it can forecast a fut…
Sponsor: Guangdong Provincial People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Heart attack diagnosis revolution? new method could save lives
Diagnosis OngoingThis study tests a new way to classify heart attacks based on whether a coronary artery is fully blocked (occlusion) or not, instead of the traditional ST-elevation vs non-ST-elevation method. Researchers will compare outcomes in 6,000 patients to see if the new approach leads to…
Phase: NA • Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 13:02 UTC
-
6,000 heart attack patients enrolled in major registry study
Knowledge-focused TerminatedThis study is a registry that will follow 6,000 people who had a heart attack and were treated with emergency angioplasty at Zhongshan Hospital. Researchers will collect information on their health, procedures, and medications, and track their recovery for up to two years. The go…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New scan method could prevent unnecessary stents after heart attacks
Knowledge-focused OngoingThis study looks at 90 people who recently had a heart attack and have other artery narrowings that may or may not be dangerous. Researchers will use two types of scans—optical coherence tomography (OCT) and magnetic resonance angiography (MRA)—to see if they can tell which narro…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart attack patients get a closer look: MRI study aims to sharpen prognosis
Knowledge-focused OngoingThis study looks at whether a special heart MRI, done within a week of a heart attack, can help doctors better predict a patient's future health. Researchers will follow 2,000 adults for years to track serious heart events like another attack or heart failure. The goal is to lear…
Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can better Decision-Making save heart attack victims in shock?
Knowledge-focused OngoingThis study looks at how doctors treat people having a severe heart attack complicated by cardiogenic shock, where the heart can't pump enough blood. Researchers will track 124 patients at 20 U.S. hospitals to see how decisions about using mechanical heart support devices affect s…
Sponsor: Henry Ford Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
2,000 heart attack patients enrolled in landmark Data-Gathering study
Knowledge-focused OngoingThis study is observing 2,000 people who have had a heart attack to collect detailed medical information, images, and blood samples. Researchers will use this data to better understand different types of heart attacks and find new ways to predict and prevent future heart problems…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood test could predict future heart trouble after heart attack
Knowledge-focused ENROLLING_BY_INVITATIONThis study involves 240 people who had a severe heart attack (STEMI) and received emergency treatment to open blocked arteries (PCI). Researchers want to find out if certain blood markers (OxPLs) can help predict the risk of future heart problems. They will use this information t…
Sponsor: First Affiliated Hospital of Ningbo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
AI could revolutionize heart attack care, new study hopes
Knowledge-focused OngoingThis study is testing a new AI-powered decision support system designed to help doctors diagnose and treat acute myocardial infarction (heart attack) more quickly and effectively. The system aims to address common delays in care, such as slow diagnosis in clinics and low complian…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Heart attack MRI registry aims to predict future risks
Knowledge-focused OngoingThis study is collecting information from 500 people who had a first heart attack and received a cardiac MRI. The goal is to see if MRI images of the heart can help predict who will have future heart problems like heart failure or need a heart transplant. Researchers are looking …
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Heart attack may spark brain inflammation, tiny study hints
Knowledge-focused OngoingThis study uses a special PET/MRI scan with an investigational tracer called [18F]DPA-714 to see if a heart attack leads to inflammation in the brain. Researchers will compare 6 people who recently had a heart attack with a control group. The goal is to better understand the link…
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Heart artery study tests which tool best protects tiny vessels
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at three ways to treat severely hardened heart arteries before placing a stent: using sound waves (lithotripsy), a high-pressure balloon, or a tiny rotating device (orbital atherectomy). The goal is to see how each method affects the small blood vessels in the he…
Phase: NA • Sponsor: Medical University of Silesia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Massive study tests diabetes drug for heart attack recovery
Knowledge-focused OngoingThis study looks at whether a common diabetes medicine (SGLT2 inhibitor) can help prevent future heart problems in people with type 2 diabetes who have had a heart attack. Researchers will compare health records of 200,000 adults in Korea who took either an SGLT2 inhibitor or ano…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New Dual-Imaging catheter aims to spot dangerous heart plaques
Knowledge-focused TerminatedThis study was designed to test a new catheter that takes two types of pictures inside heart arteries at the same time—using sound and light. The goal was to see if this hybrid approach is safer and better at identifying fatty plaques that could cause heart attacks compared to st…
Phase: NA • Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:31 UTC
-
Heart study pulled before it began: plan to tackle poverty and readmissions scrapped
Knowledge-focused TerminatedThis study was designed to see if helping heart patients with social problems like food, housing, and mental health could keep them out of the hospital. The researchers planned to screen patients and connect them to community resources. However, the study was withdrawn before enr…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:10 UTC